Skip to main content
ELI LILLY & Co logo

ELI LILLY & Co — Investor Relations & Filings

Ticker · LLY ISIN · US5324571083 LEI · FRDRIPF3EKNDJ2CQJL29 US Manufacturing
Open in API
Filings indexed 3,870 across all filing types
Latest filing 2019-02-26 M&A Activity
Country US United States of America
Listing US LLY

About ELI LILLY & Co

https://www.lilly.com/

Eli Lilly and Company is a global, research-based medicine company that discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on creating treatments in key therapeutic areas, including diabetes, obesity, immunology, oncology, and neuroscience. Leveraging biotechnology and chemistry, it develops medicines for some of the world's most significant health challenges. Historically known for the commercialization of insulin, the company continues to be a major provider of therapies for chronic diseases. Its stated purpose is to unite caring with discovery to create medicines that make life better for people around the world.

Recent filings

Filing Released Lang Actions
425 Filing
M&A Activity Classification · 95% confidence The document is filed pursuant to Rule 425 under the Securities Act of 1933, which relates to communications in connection with a merger or acquisition transaction. The text describes an exchange offer by Eli Lilly and Company to exchange shares of Elanco Animal Health Incorporated for shares of Lilly common stock. It includes detailed terms of the exchange offer, indicative exchange ratios, and references to a prospectus and other offer documents. The document is not a full annual or quarterly report, nor is it a simple announcement or press release. It is a communication related to a merger or acquisition transaction, specifically an exchange offer, which fits the category of M&A Activity filings under Rule 425. Therefore, the appropriate classification is TAR (M&A Activity). The document length is substantial (15,000 characters), indicating it is the actual communication, not just an announcement or notice.
2019-02-26 English
FORM 4 SUBMISSION
Director's Dealing
2019-02-25 English
Eli Lilly and Company: Eli Lilly and Company Files Preliminary Proxy
AGM Information Classification · 95% confidence The document is a short announcement informing shareholders about the upcoming 2019 Annual General Meeting (AGM) of Eli Lilly and Company, including the date, record date for voting, and where to find related documents such as the Annual Report on Form 10-K and proxy statements. It does not contain the actual AGM materials or the Annual Report itself, but rather directs shareholders to where these can be accessed. The document length is only 1613 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE, this is a Report Publication Announcement or a meeting call notice. The best fitting category is AGM Information (AGM-R) as it is a call for the Annual General Meeting and related shareholder information.
2019-02-25 English
425 Filing
Merger & Acquisition Classification · 100% confidence The document is filed by Eli Lilly and Company pursuant to Rule 425 under the Securities Act of 1933, which relates to communications in connection with a merger or acquisition transaction. The text describes an exchange offer by Eli Lilly to exchange shares of Elanco Animal Health for shares of Lilly common stock. It includes detailed terms of the exchange offer, indicative exchange ratios, VWAP calculations, and references to a Prospectus. The document is a communication related to a merger or acquisition transaction, specifically an exchange offer, and is filed under Rule 425, which is used for merger communications. This fits the category of Merger & Acquisition (MA) filings, which include merger communications such as Form 425 filings. The document is lengthy (15,000 characters) and contains substantive information about the transaction, not just an announcement or a link to a report, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the correct classification is Merger & Acquisition (MA).
2019-02-25 English
Eli Lilly and Company Files Preliminary Proxy
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'SCHEDULE 14A' and is identified as a 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It includes detailed information about the 2019 Annual Meeting of Shareholders for Eli Lilly and Company, including items of business such as election of directors, advisory votes on executive compensation, ratification of auditors, and shareholder proposals. The document contains governance information, director qualifications, compensation discussion, and voting logistics. The presence of detailed proxy solicitation materials and voting recommendations confirms this is a Proxy Solicitation & Information Statement. It is not an announcement of a report, nor a full annual report or earnings release. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI).
2019-02-25 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, as indicated by the header and the text. It includes detailed information about the upcoming 2019 Annual Meeting of Shareholders for Eli Lilly and Company, including items of business such as election of directors, advisory vote on executive compensation, ratification of auditors, and shareholder proposals. The document contains governance information, director qualifications, compensation discussion and analysis, and other proxy-related materials. It is not a full annual report or financial statement but rather the proxy solicitation materials sent to shareholders to inform and request votes for the annual meeting. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the proxy statement itself, not just an announcement or a brief summary.
2019-02-23 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.